Renub

    United States Proton Therapy Market, Size, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Growth, Opportunity Company Analysis

    Excel: 12 Hours
    PDF: 24 Hours
    Jan 2022

    United States Proton Therapy Market Outlook

    The United States Proton Therapy Market is expected to reach US$ 1.8 Billion by 2027. Proton therapy is an excellent treatment alternative for numerous patients, especially those with tumours close to vital organs. Besides, for children, those most vulnerable and susceptive to the damage of conventional radiation therapy, proton therapy offers less radiation exposure while demoting side effects. In addition, proton therapy is a high-tech option for X-ray radiation. With online image guidance, a scanning beam of proton radiation advises greater precision to destroy carcinogenic cells, sparing adjacent healthy tissue with more infrequent side effects.

     

    united states proton therapy market


    COVID-19 Impact on United States Proton Therapy Industry:

    Despite the outbreak of COVID-19 worldwide, the proton therapy market has increased at a constant speed. It was only stopped for a brief period in the initial months of the pandemic outbreak but later resumed to take care of the cancer patients and radiation therapies patients in the United States; many procedures have been finalized to help the patients with therapies. Such as, many implementations and algorithms have been carried out to safeguard the radiation patients from COVID-19.


    United States Proton Therapy Market will grow with a CAGR of 8.5% during the period 2021-2027

    The rise of the proton therapy industry in the United States is mainly driven by rising healthcare expenditure, expanding preference for advanced therapies by healthcare practitioners, increasing confirmation and increasing cancer pervasiveness. Another outstanding growth driver is the faster uptake and access along with premium pricing. As per our analysis, United States Proton Therapy Market Size was US$ 1.1 Billion post-pandemic recoveries in 2021.


    Cancer Types - Market Segmentation:

    Based on Cancer Types, the proton therapy market of the United States is further segmented into Central Nervous System Tumors, Intraocular Melanomas Cancer, Pituitary Neoplasms Cancer, Base of Skull / Axial Skeleton Cancer, Head and Neck Cancer, Lung Cancer, Retroperitoneal Sarcoma Cancer, Pediatric Cancer (Up to Age 18), Gastrointestinal Tract Cancer, Urinary Tract Cancer, Female Pelvic Organs Cancer, Prostate Cancer, and Breast Cancer.


    Besides, proton therapy applications are more inclined towards Gastrointestinal Tract Cancer and lung cancer due to references by healthcare specialists. Moreover, proton therapy is also recognized to be comparatively safer in the case of paediatric patients who have cancer. These applications are anticipated to drive the revenue for the proton therapy industry over the forecast period.

     

    us proton therapy market


    Competitive Landscape:

    Companies in the United States Proton Therapy Market are trying to create their mark by adopting new technologies at an accelerated rate. The company has also tried to enrich their product catalogues through product developments. Also, companies have acquired small companies to resolve the potential resource gap that prevailed in their technologies and products. The major players of the United States Proton Therapy Market studied in our report are IBA Proton Therapy, Varian Medical Systems, and Elekta.


    Renub Research latest report “Proton Therapy Patients Number & Market, Global Forecast By Cancer Types (Central Nervous System Tumors, Intraocular Melanomas Cancer, Pituitary Neoplasms Cancer, Base of Skull / Axial Skeleton Cancer, Head and Neck Cancer, Lung Cancer, Retroperitoneal Sarcoma Cancer, Pediatric Cancer (Up to Age 18), Gastrointestinal Tract Cancer, Urinary Tract Cancer, Female Pelvic Organs Cancer, Prostate Cancer, Breast Cancer and Others), Company (IBA Proton Therapy, Varian Medical Systems, Elekta)” provides a detailed analysis of United States Proton Therapy Industry.


    Cancer Types – United States Proton Therapy Market has been covered from 14 viewpoints:

    1.    Central Nervous System Tumors
    2.    Intraocular Melanomas Cancer
    3.    Pituitary Neoplasms Cancer
    4.    Base of Skull / Axial Skeleton Cancer
    5.    Head and Neck Cancer
    6.    Lung Cancer
    7.    Retroperitoneal Sarcoma Cancer
    8.    Pediatric Cancer Cases (Up to Age 18)
    9.    Gastrointestinal Tract Cancer
    10.    Urinary Tract Cancer
    11.    By Female Pelvic Organs Cancer
    12.    Prostate Cancer
    13.    Breast Cancer
    14.    Other Cancer

     

    united states proton therapy industry size


    Cancer Types – Patients Number in United States Proton Therapy Market has been covered from 14 viewpoints:

    1.    Central Nervous System Tumors
    2.    Intraocular Melanomas Cancer
    3.    Pituitary Neoplasms Cancer
    4.    Base of Skull / Axial Skeleton Cancer
    5.    Head and Neck Cancer
    6.    Lung Cancer
    7.    Retroperitoneal Sarcoma Cancer
    8.    Pediatric Cancer (Up to Age 18)
    9.    Gastrointestinal Tract Cancer
    10.    Urinary Tract Cancer
    11.    Female Pelvic Organs Cancer
    12.    Prostate Cancer
    13.    Breast Cancer
    14.    Other Cancer


    All companies have been covered from 3 viewpoints:

    •    Overview
    •    Recent Developments
    •    Sales Analysis


    Companies Covered:

    1.    IBA Proton Therapy
    2.    Varian Medical Systems
    3.    Elekta

    1.    Introduction

    2.    Research & Methodology
    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    Market (Actual & Potential) – United States Proton Therapy Market

    5.1    Actual Proton Therapy Market
    5.2    Potential Proton Therapy Market


    6.    Number of Patients – United States Proton Therapy

    6.1    Actual Numbers
    6.2    Potential Numbers


    7.    Cancer Types – United States Proton Therapy Market

    7.1    Central Nervous System Tumors
    7.2    Intraocular Melanomas Cancer
    7.3    Pituitary Neoplasms Cancer
    7.4    Base of Skull / Axial Skeleton Cancer
    7.5    Head and Neck Cancer
    7.6    Lung Cancer
    7.7    Retroperitoneal Sarcoma Cancer
    7.8    Pediatric Cancer Cases (Up to Age 18)
    7.9    Gastrointestinal Tract Cancer
    7.10    Urinary Tract Cancer
    7.11    By Female Pelvic Organs Cancer
    7.12    Prostate Cancer
    7.13    Breast Cancer
    7.14    Other Cancer


    8.    Cancer Types – United States Proton Therapy Patients Numbers

    8.1    Central Nervous System Tumors
    8.2    Intraocular Melanomas Cancer
    8.3    Pituitary Neoplasms Cancer
    8.4    Base of Skull / Axial Skeleton Cancer
    8.5    Head and Neck Cancer
    8.6    Lung Cancer
    8.7    Retroperitoneal Sarcoma Cancer
    8.8    Pediatric Cancer (Up to Age 18)
    8.9    Gastrointestinal Tract Cancer
    8.10    Urinary Tract Cancer
    8.11    Female Pelvic Organs Cancer
    8.12    Prostate Cancer
    8.13    Breast Cancer
    8.14    Other Cancer


    9.    United States – List of Proton Therapy Centers

    9.1    Operating Proton Therapy Centers
    9.2    Under-Construction Therapy Centers
    9.3    Planning Proton Therapy Centers


    10.    Proton Therapy – Reimbursement Policies

    10.1    Proton Therapy Reimbursement Policies for Patients
    10.2    Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers


    11.    Components of a Standard Proton Therapy Center

    11.1    Proton Accelerator

    11.1.1    Synchrotrons (example: LLUMC at Loma Linda)
    11.1.2    Cyclotrons (example: MGH Boston)
    11.1.3    Synchrocyclotrons (examples: Orsay, Uppsala)
    11.1.4    Linacs (Rome)
    11.1.5    H-minus Synchrotrons
    11.1.6    Separated Sector Cyclotrons
    11.1.7    Super-conducting Cyclotrons
    11.1.8    Fast Cycling Synchrotron

    11.2    Beam Transport System

    11.3    Beam Delivery System

    11.3.1    The Passive Scattering Technique
    11.3.2    Beam Scanning

    11.4    Nozzle

    11.4.1    Single Scattering
    11.4.2    Double Scattering
    11.4.3    Uniform Scanning Nozzle
    11.4.4    Pencil Scanning Nozzle

    11.5    Treatment Planning System
    11.6    Image Viewers
    11.7    Patient Positioning System (PPS)
    11.8    Human Resource


    12.    Porters Five Forces

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes


    13.    Company Analysis

    13.1    IBA Proton Therapy

    13.1.1    Overview
    13.1.2    Recent Developments
    13.1.3    Sales Analysis

    13.2    Varian Medical Systems

    13.2.1    Overview
    13.2.2    Recent Developments
    13.2.3    Sales Analysis

    13.3    Elekta

    13.3.1    Overview
    13.3.2    Recent Developments
    13.3.3    Sales Analysis

    • Description
      Price
    • Chapter 1, 2, 3, 4 & 5     Pages : 14
      $1,000
    • Chapter 6     Pages : 7
      $900
    • Chapter 7     Pages : 45
      $900
    • Chapter 8     Pages : 45
      $900
    • Chapter 9     Pages : 10
      $500
    • Chapter 10     Pages : 5
      $500
    • Chapter 11.1     Pages : 8
      $500
    • Chapter 11.2 & 11.2     Pages : 3
      $300
    • Chapter 11.4     Pages : 4
      $300
    • Chapter 11.5, 11.6, 11.7 & 11.8     Pages : 4
      $400
    • Chapter 12     Pages : 6
      $400
    • Chapter 13.1     Pages : 5
      $150
    • Chapter 13.2     Pages : 5
      $150
    • Chapter 13.3     Pages : 5
      $150

    Related Reports